{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:53:55Z","timestamp":1790758435153,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.acvd.2025.04.056","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T02:53:42Z","timestamp":1749696822000},"page":"514-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antithrombotic approach in percutaneous pulmonary valve implantation (PPVI): What is our standard of care? A study endorsed by the Association for European Paediatric and Congenital Cardiology"],"prefix":"10.1016","volume":"118","author":[{"given":"Alessia","family":"Callegari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Butera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Krasemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Heying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Michel-Behnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Malekzadeh-Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.acvd.2025.04.056_bib0245","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/eurheartj\/ehz201","article-title":"Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation","volume":"40","author":"Nordmeyer","year":"2019","journal-title":"Eur Heart J"},{"issue":"AA","key":"10.1016\/j.acvd.2025.04.056_bib0250","first-page":"AA60","article-title":"Percutaneous pulmonary valve implantation: what have we learned over the years? EuroIntervention J Eur Collab Work Group","volume":"13","author":"Boudjemline","year":"2017","journal-title":"Interv Cardiol Eur Soc Cardiol"},{"issue":"9239","key":"10.1016\/j.acvd.2025.04.056_bib0255","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(00)02844-0","article-title":"Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction","volume":"356","author":"Bonhoeffer","year":"2000","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.acvd.2025.04.056_bib0260","first-page":"E653","article-title":"Early clinical experience with the straight design of Venus P-valve\u2122 in dysfunctional right ventricular outflow tracts","volume":"96","author":"Morgan","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.acvd.2025.04.056_bib0265","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17434440.2021.1857728","article-title":"Prevention and management of endocarditis after transcatheter pulmonary valve replacement: current status and future prospects","volume":"18","author":"McElhinney","year":"2021","journal-title":"Expert Rev Med Devices"},{"issue":"7","key":"10.1016\/j.acvd.2025.04.056_bib0270","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/s00246-021-02652-8","article-title":"Aspirin use and transcatheter pulmonary valve replacement, the need for consistency","volume":"42","author":"Shibbani","year":"2021","journal-title":"Pediatr Cardiol"},{"issue":"6","key":"10.1016\/j.acvd.2025.04.056_bib0275","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacc.2021.05.044","article-title":"Multicenter study of endocarditis after transcatheter pulmonary valve replacement","volume":"78","author":"McElhinney","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.acvd.2025.04.056_bib0280","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.jacc.2020.04.043","article-title":"Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 Cardiac Computed Tomography Substudy","volume":"75","author":"Makkar","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.acvd.2025.04.056_bib0285","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.jacc.2011.07.040","article-title":"Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial","volume":"58","author":"Kenny","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.acvd.2025.04.056_bib0290","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/ehjci\/jead260","article-title":"Auto-expandable pulmonary valve leaflet microthrombosis: a subtle and dangerous phenomenon","volume":"25","author":"Pilati","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.acvd.2025.04.056_bib0295","first-page":"1078","article-title":"Right ventricular outflow tract obstruction associated with neointimal tissue accumulation and distortion of the Harmony TPV25 stent frame: potential mechanisms and treatment","volume":"102","author":"Steinberg","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.acvd.2025.04.056_bib0300","first-page":"660","article-title":"2024 Statement from Asia expert operators on transcatheter pulmonary valve replacement","volume":"103","author":"Pan","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.acvd.2025.04.056_bib0305","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/infdis\/jiu426","article-title":"Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans?","volume":"211","author":"Veloso","year":"2015","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.acvd.2025.04.056_bib0310","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1128\/iai.64.12.4915-4921.1996","article-title":"Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis","volume":"64","author":"Sullam","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.acvd.2025.04.056_bib0315","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2019.01.095","article-title":"Subclinical thrombus formation in bioprosthetic pulmonary valve conduits","volume":"281","author":"Jewgenow","year":"2019","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.acvd.2025.04.056_bib0320","first-page":"600","article-title":"Non-infectious thrombosis of the Melody\u00ae valve: a tale of two cities","volume":"88","author":"Schneider","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.acvd.2025.04.056_bib0325","first-page":"925","article-title":"Early leaflet thrombosis complicating transcatheter implantation of a Sapien 3 valve in a native right ventricular outflow tract","volume":"92","author":"Riahi","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.acvd.2025.04.056_bib0330","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jcmg.2021.04.023","article-title":"Hypoattenuated leaflet thickening after transcatheter pulmonary valve replacement with the SAPIEN 3 valve","volume":"14","author":"Hammadah","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.acvd.2025.04.056_bib0335","doi-asserted-by":"crossref","first-page":"101632","DOI":"10.1016\/j.cpcardiol.2023.101632","article-title":"Optimal anticoagulation on TAVI patients based on thrombotic and bleeding risk and the challenge beyond: a systematic review and meta-analysis","volume":"48","author":"Tsoumas","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.acvd.2025.04.056_bib0340","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ahj.2023.08.010","article-title":"An investigator-sponsored pragmatic randomized controlled trial of anticoagulation vs. acetylsalicylic acid after transcatheter aortic valve implantation: rationale and design of ACASA-TAVI","volume":"265","author":"Dodgson","year":"2023","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.acvd.2025.04.056_bib0345","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.jtcvs.2012.01.006","article-title":"Atypical malignant late infective endocarditis of Melody valve","volume":"143","author":"Patel","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.acvd.2025.04.056_bib0350","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacbts.2022.09.009","article-title":"Calcification in pulmonary heart valve tissue engineering: a systematic review and meta-analysis of large-animal studies","volume":"8","author":"van der Valk","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.acvd.2025.04.056_bib0355","doi-asserted-by":"crossref","first-page":"1270496","DOI":"10.3389\/fcvm.2023.1270496","article-title":"Development and testing of a transcatheter heart valve with reduced calcification potential","volume":"10","author":"Weich","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"19","key":"10.1016\/j.acvd.2025.04.056_bib0360","doi-asserted-by":"crossref","first-page":"e018506","DOI":"10.1161\/JAHA.120.018506","article-title":"Degeneration of bioprosthetic heart valves: update 2020","volume":"9","author":"Kostyunin","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.acvd.2025.04.056_bib0365","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.acvd.2023.01.008","article-title":"Infective endocarditis after transcatheter pulmonary valve implantation in patients with congenital heart disease: distinctive features","volume":"116","author":"Lourtet-Hasco\u00ebt","year":"2023","journal-title":"Arch Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.acvd.2025.04.056_bib0370","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.acvd.2014.09.003","article-title":"Incidence and predictors of Melody\u00ae valve endocarditis: a prospective study","volume":"108","author":"Malekzadeh-Milani","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.acvd.2025.04.056_bib0375","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/biomedicines10020263","article-title":"Aspirin and infection: a narrative review","volume":"10","author":"Di Bella","year":"2022","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.acvd.2025.04.056_bib0380","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacbts.2023.02.003","article-title":"Protective effect of ticagrelor against infective endocarditis induced by virulent Staphylococcus aureus in mice","volume":"8","author":"Oury","year":"2023","journal-title":"JACC Basic Transl Sci"},{"issue":"2","key":"10.1016\/j.acvd.2025.04.056_bib0385","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jtcvs.2018.04.053","article-title":"Are plasma proteins key players in the pathogenesis of infective endocarditis?","volume":"156","author":"Veloso","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.acvd.2025.04.056_bib0390","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1016\/j.jtcvs.2019.10.188","article-title":"Antiplatelet therapy abrogates platelet-assisted Staphylococcus aureus infectivity of biological heart valve conduits","volume":"161","author":"Ditkowski","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"24","key":"10.1016\/j.acvd.2025.04.056_bib0395","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.3390\/jcm12247632","article-title":"Antithrombotic management for transcatheter aortic valve implantation","volume":"12","author":"Ya\u2019Qoub","year":"2023","journal-title":"J Clin Med"},{"issue":"24","key":"10.1016\/j.acvd.2025.04.056_bib0400","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.jcin.2021.09.019","article-title":"Subclinical Leaflet thrombosis after transcatheter aortic valve replacement: a meta-analysis","volume":"14","author":"Bogyi","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.acvd.2025.04.056_bib0405","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.acvd.2023.09.006","article-title":"Transfemoral versus trans-subclavian access in transcatheter aortic valve implantation using self-expandable valve: a propensity-matched comparison","volume":"116","author":"Bennes","year":"2023","journal-title":"Arch Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.acvd.2025.04.056_bib0410","doi-asserted-by":"crossref","first-page":"e2200","DOI":"10.1002\/hsr2.2200","article-title":"Subclinical leaflet thrombosis and anticoagulation strategy following trans-catheter aortic valve replacement: a systematic review","volume":"7","author":"Shashank","year":"2024","journal-title":"Health Sci Rep"},{"issue":"6","key":"10.1016\/j.acvd.2025.04.056_bib0415","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.122.059512","article-title":"Edoxaban versus dual antiplatelet therapy for leaflet thrombosis and cerebral thromboembolism after TAVR: the ADAPT-TAVR randomized clinical trial","volume":"146","author":"Park","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.acvd.2025.04.056_bib0420","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10557-021-07145-7","article-title":"Aspirin alone versus dual antiplatelet therapy after transcatheter aortic valve replacement: a systematic review and meta-analysis","volume":"36","author":"Lin","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.acvd.2025.04.056_bib0425","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.thromres.2023.10.017","article-title":"Risk factors for serious adverse events related to vitamin K antagonists in children with congenital or acquired heart disease: a prospective cohort study","volume":"232","author":"Bajolle","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2025.04.056_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2015.12.013","article-title":"Risk of major bleeding in patients receiving vitamin K antagonists or low doses of aspirin. A systematic review and meta-analysis","volume":"138","author":"Vazquez","year":"2016","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.acvd.2025.04.056_bib0435","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.107.715821","article-title":"Dosing of clopidogrel for platelet inhibition in infants and young children","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2025.04.056_bib0440","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjcard.2024.06.026","article-title":"Performance and failure of right ventricle to pulmonary artery conduit in congenital heart disease","volume":"226","author":"D\u2019Angelo","year":"2024","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.acvd.2025.04.056_bib0445","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/eurheartj\/ehad663","article-title":"Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry","volume":"45","author":"Hasco\u00ebt","year":"2024","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.acvd.2025.04.056_bib0450","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/1573403X15666181224113855","article-title":"Percutaneous pulmonary valve implantation: current status and future perspectives","volume":"15","author":"Driesen","year":"2019","journal-title":"Curr Cardiol Rev"},{"issue":"2","key":"10.1016\/j.acvd.2025.04.056_bib0455","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00246-024-03449-1","article-title":"Aspirin responsiveness in a cohort of pediatric patients with right ventricle to pulmonary artery conduits and transcatheter valve replacement systems","volume":"46","author":"Kelleher","year":"2024","journal-title":"Pediatr Cardiol"},{"issue":"39","key":"10.1016\/j.acvd.2025.04.056_bib0460","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.acvd.2025.04.056_bib0465","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejcts.2010.01.063","article-title":"Comparison of bovine jugular vein with pulmonary homograft conduits in children less than 2 years of age","volume":"38","author":"Fiore","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.acvd.2025.04.056_bib0470","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbaa049","article-title":"The study of dry biological valve crosslinked with a combination of carbodiimide and polyphenol","volume":"8","author":"Yang","year":"2020","journal-title":"Regen Biomater"},{"issue":"332","key":"10.1016\/j.acvd.2025.04.056_bib0475","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.morpho.2016.06.003","article-title":"Correlation between structural changes and acute thrombogenicity in transcatheter pericardium valves after crimping and balloon deployment","volume":"101","author":"Bourget","year":"2017","journal-title":"Morphologie"},{"key":"10.1016\/j.acvd.2025.04.056_bib0480","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.actbio.2024.10.045","article-title":"Polymeric artificial heart valves derived from modified diol-based polycarbonate polyurethanes","volume":"190","author":"Hu","year":"2024","journal-title":"Acta Biomater"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213625003250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213625003250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:10:40Z","timestamp":1761412240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213625003250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1875213625003250"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2025.04.056","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic approach in percutaneous pulmonary valve implantation (PPVI): What is our standard of care? A study endorsed by the Association for European Paediatric and Congenital Cardiology","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2025.04.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}